PENTAX Medical names Dr. Hudson Garrett global chief clinical officer, FDA approves Gilead Sciences' new chronic HCV drug — 6 GI company key notes

Here are six recent news updates on key gastroenterology and endoscopy companies.

Hudson Garrett, PhD, is PENTAX Medical's new global chief clinical officer.

The American Gastroenterological Association Research Foundation and Takeda Pharmaceuticals U.S.A. are offering three new research grants to fund work on inflammatory bowel disease projects.

GI Dynamics announced the final results of its ENDO Trial, the clinical trial for its EndoBarrier therapy in the United States.

The U.S. Preventive Services Task Force included Exact Sciences' Cologuard in its final 2016 colorectal cancer screening recommendations and clarified Cologuard's position as equal to other recommended screening tests.

Healthmark Industries launched the NOW! test for checking endoscope safety.

The FDA approved Gilead Sciences' Epclusa to treat adults with chronic hepatitis C, both with and without cirrhosis.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast